Komori
Annual Securities Report4978ReproCELL IncorporatedChemicals

Annual Securities Report — FY2025

What ReproCELL Incorporated reported for the period from 2025-04-01 to 2026-03-31.

How much it says
58Typical
What moved here
49named for the first time
Its own wording
75terms
Which filing this is
33/ 33newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

The Group reported a loss for the period, with revenue of ¥2,233,519 thousand and a net loss attributable to owners of the parent of ¥591,693 thousand for the current period (1 April 2025 to 31 March 2026). In addition, the subsequent events section describes a share and stock acquisition rights issuance program, approved on 27 May 2026, with CVI Investments, Inc. as the intended allottee, after the Annual Securities Report filing date.

Komori's summary of this document, not the document's own words.
58Typical
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 34 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
Magnitude of change
70
Detailed
Strategic shift
54
Typical
Capital movements
62
Detailed
Disclosure Gaps
0
Almost nothing
Concentration Risk
68
Detailed
Change in Risk
55
Typical
Financial and Capital Policy
60
Detailed
Product portfolio
79
Very detailed
Technology Position
50
Typical
Confidence in Strategic Bets
R&D spend6億円Money spent making new things.
Cash left over-5億円Cash from the business, less what went into equipment.
Spent on equipment98百万円Plants, machines — things meant to last.
Employees101Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
ReproCELL Incorporated — FY2025 | Komori